A Trial of Amitriptyline and Fluphenazine in the Treatment of Painful Diabetic Neuropathy

Carl M. Mendel, Robert Klein, David A. Chappell, Willard H. Dere, Barry J. Gertz, John H. Karam, Thomas N. Lavin, Carl Grunfeld

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

We conducted a double-blind, placebo-controlled, crossover study of the effectiveness of amitriptyline and fluphenazine in alleviating the pain of diabetic peripheral neuropathy in six diabetic patients. Pain was evaluated by the patients with a graphic rating scale. A placebo response was found, but no additional effect of amitriptyline and fluphenazine was seen. Although the statistical power of this study was low, these data, when combined with a reevaluation of previous trials of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathy, indicate that there is no justification for the use of these agents in the treatment of painful neuropathy outside of large, controlled clinical trials. Depression as a possible cause of this condition should not go unnoted or untreated.

Original languageEnglish (US)
Pages (from-to)637-639
Number of pages3
JournalJAMA - Journal of the American Medical Association
Volume255
Issue number5
DOIs
StatePublished - Feb 7 1986
Externally publishedYes

Fingerprint

Fluphenazine
Amitriptyline
Diabetic Neuropathies
Placebos
Pain
Controlled Clinical Trials
Peripheral Nervous System Diseases
Cross-Over Studies
Therapeutics
Depression

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A Trial of Amitriptyline and Fluphenazine in the Treatment of Painful Diabetic Neuropathy. / Mendel, Carl M.; Klein, Robert; Chappell, David A.; Dere, Willard H.; Gertz, Barry J.; Karam, John H.; Lavin, Thomas N.; Grunfeld, Carl.

In: JAMA - Journal of the American Medical Association, Vol. 255, No. 5, 07.02.1986, p. 637-639.

Research output: Contribution to journalArticle

Mendel, Carl M. ; Klein, Robert ; Chappell, David A. ; Dere, Willard H. ; Gertz, Barry J. ; Karam, John H. ; Lavin, Thomas N. ; Grunfeld, Carl. / A Trial of Amitriptyline and Fluphenazine in the Treatment of Painful Diabetic Neuropathy. In: JAMA - Journal of the American Medical Association. 1986 ; Vol. 255, No. 5. pp. 637-639.
@article{ba4343c7b9b842b6a5df7e58d6acc0b1,
title = "A Trial of Amitriptyline and Fluphenazine in the Treatment of Painful Diabetic Neuropathy",
abstract = "We conducted a double-blind, placebo-controlled, crossover study of the effectiveness of amitriptyline and fluphenazine in alleviating the pain of diabetic peripheral neuropathy in six diabetic patients. Pain was evaluated by the patients with a graphic rating scale. A placebo response was found, but no additional effect of amitriptyline and fluphenazine was seen. Although the statistical power of this study was low, these data, when combined with a reevaluation of previous trials of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathy, indicate that there is no justification for the use of these agents in the treatment of painful neuropathy outside of large, controlled clinical trials. Depression as a possible cause of this condition should not go unnoted or untreated.",
author = "Mendel, {Carl M.} and Robert Klein and Chappell, {David A.} and Dere, {Willard H.} and Gertz, {Barry J.} and Karam, {John H.} and Lavin, {Thomas N.} and Carl Grunfeld",
year = "1986",
month = "2",
day = "7",
doi = "10.1001/jama.1986.03370050079025",
language = "English (US)",
volume = "255",
pages = "637--639",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "5",

}

TY - JOUR

T1 - A Trial of Amitriptyline and Fluphenazine in the Treatment of Painful Diabetic Neuropathy

AU - Mendel, Carl M.

AU - Klein, Robert

AU - Chappell, David A.

AU - Dere, Willard H.

AU - Gertz, Barry J.

AU - Karam, John H.

AU - Lavin, Thomas N.

AU - Grunfeld, Carl

PY - 1986/2/7

Y1 - 1986/2/7

N2 - We conducted a double-blind, placebo-controlled, crossover study of the effectiveness of amitriptyline and fluphenazine in alleviating the pain of diabetic peripheral neuropathy in six diabetic patients. Pain was evaluated by the patients with a graphic rating scale. A placebo response was found, but no additional effect of amitriptyline and fluphenazine was seen. Although the statistical power of this study was low, these data, when combined with a reevaluation of previous trials of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathy, indicate that there is no justification for the use of these agents in the treatment of painful neuropathy outside of large, controlled clinical trials. Depression as a possible cause of this condition should not go unnoted or untreated.

AB - We conducted a double-blind, placebo-controlled, crossover study of the effectiveness of amitriptyline and fluphenazine in alleviating the pain of diabetic peripheral neuropathy in six diabetic patients. Pain was evaluated by the patients with a graphic rating scale. A placebo response was found, but no additional effect of amitriptyline and fluphenazine was seen. Although the statistical power of this study was low, these data, when combined with a reevaluation of previous trials of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathy, indicate that there is no justification for the use of these agents in the treatment of painful neuropathy outside of large, controlled clinical trials. Depression as a possible cause of this condition should not go unnoted or untreated.

UR - http://www.scopus.com/inward/record.url?scp=84944283429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944283429&partnerID=8YFLogxK

U2 - 10.1001/jama.1986.03370050079025

DO - 10.1001/jama.1986.03370050079025

M3 - Article

C2 - 3511312

AN - SCOPUS:84944283429

VL - 255

SP - 637

EP - 639

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 5

ER -